Clinical Trial Update: Factors Determining the Efficacy of Botulinum Toxin for Arm Tremor in Dystonia [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is evaluating factors that determine the efficacy of botulinum toxin for arm tremor in dystonic tremor syndrome (recruiting).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dystonic Tremor Syndrome

Drugs mentioned

• Botulinum toxin (botulinum toxin)

Snippet

Sponsor: Radboud University Medical Center | Conditions: Dystonic Tremor Syndrome | Phase 4 | Status: RECRUITING